Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01661036 · ClinicalTrials.gov registry record
Testing the FLASHE Survey
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 36
- Enrollment target
NCT01661036: Completed study, sponsored by National Cancer Institute (NCI).
NCT01661036 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01661036 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Background: \- The Family Life, Activity, Sun, Health, and Eating (FLASHE) Survey is designed to look at health-related topics. It is being developed for the Department of Health and Human Services. Researchers want to see how easy or difficult the FLASHE survey questions are to understand and answer. They will interview parents and teenagers to test the survey questions. Objectives: \- To test the FLASHE survey questions on teenagers and their parents. Eligibility: * Adolescents between 11 and 18 years of age. * Parents of the participating adolescents. Design: * Participants will have a one-on-one interview to test the survey questions. The interview will last up to an hour and a half. Participants will be allowed to skip any questions that they do not wish to answer. * Participants will receive financial compensation for their time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-07-23 |
| Est. Completion | 2015-08-07 |
What the finished NCT01661036 record still lists
NCT01661036 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01661036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01661036 about?
NCT01661036 is a clinical study titled "Testing the FLASHE Survey". Background: \- The Family Life, Activity, Sun, Health, and Eating (FLASHE) Survey is designed to look at health-related topics. It is being developed for the Department of Health and Human Services. Researchers want to see how easy or difficult the FLASHE survey questions are to understand and answ...
What is the current status of trial NCT01661036?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2012-07-23. Estimated completion is 2015-08-07.
Who is sponsoring clinical trial NCT01661036?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI